Celldex Therapeutics Shares Plummet After Experimental Drug Barzolvolimab Fails Phase 2 Clinical Trial

Biotech firm Celldex Therapeutics faces market turbulence after its experimental drug barzolvolimab failed a key mid-stage clinical study for the skin condition prurigo nodularis.

Loading lens…